The diagnostic accuracy of seven commercial molecular in vitro SARS-CoV-2 detection tests: a rapid meta-analysis
- 1 June 2021
- journal article
- other
- Published by Taylor & Francis in Expert Review of Molecular Diagnostics
- Vol. 21 (7) , 733-740
Abstract
Objective: To compare the accuracy parameters of seven commercial molecular in vitro diagnostic tests for detecting SARS-CoV-2. Methods: Studies evaluating the accuracy of seven different commercial molecular diagnostic tests for detecting SARS-CoV-2 (Cepheid Xpert Xpress SARS-CoV-2 test, Simplexa COVID-19 Direct, Abbott ID NOW COVID-19, Cobas SARS-CoV-2, Allplex 2019-nCoV Assay, Panther Fusion SARS-CoV-2, and BioFire COVID-19 Test) were included. The quality of the included studies was assessed using the QUADAS-2 checklist. A bivariate random-effects regression model was implemented.. Results: Meta-analysis of 12 included studies showed that the performances of commercial COVID-19 molecular in vitro diagnostic tests were high, with a summary sensitivity of 95.9% (95% CI 93.9–97.2%, I2 = 60.22%) and specificity of 97.2% (95% CI 95.5–98.3%, I2 = 56.66%). Among seven evaluated tests, the Abbott ID NOW COVID-19 and Simplexa COVID-19 Direct displayed lower sensitivity (91.6%, 95% CI 80.5–96.6% and 92%, 95% CI 86.2–95.5, respectively). Conclusion: All evaluated tests showed good accuracy. However, the slightly lower sensitivity observed in the Abbott ID Now COVID-19 and Simplexa COVID-19 Direct should be considered when deciding on a test platform. Moreover, the diagnostic accuracy of COVID-19 commercial diagnostic tests should be weighed against their ease of use and speed.Keywords
This publication has 24 references indexed in Scilit:
- Comparison of Two Commercial Molecular Tests and a Laboratory-Developed Modification of the CDC 2019-nCoV Reverse Transcriptase PCR Assay for the Detection of SARS-CoV-2Journal of Clinical Microbiology, 2020
- Comparison of Four Molecular In Vitro Diagnostic Assays for the Detection of SARS-CoV-2 in Nasopharyngeal SpecimensJournal of Clinical Microbiology, 2020
- Comparison of Abbott ID Now, DiaSorin Simplexa, and CDC FDA Emergency Use Authorization Methods for the Detection of SARS-CoV-2 from Nasopharyngeal and Nasal Swabs from Individuals Diagnosed with COVID-19Journal of Clinical Microbiology, 2020
- Niveles de interleucina-6 en el humor acuoso en glaucoma primario de ángulo abierto (GPAA): revisión sistemática y meta-análisisArchivos de la Sociedad Española de Oftalmología, 2020
- Comparison of Cepheid Xpert Xpress and Abbott ID Now to Roche cobas for the Rapid Detection of SARS-CoV-2Journal of Clinical Virology, 2020
- Interleukin-6 levels in children developing SARS-CoV-2 infectionPediatrics & Neonatology, 2020
- Interleukin-6 as a potential biomarker of COVID-19 progressionMedecine Et Maladies Infectieuses, 2020
- Clinical Evaluation and Utilization of Multiple Molecular In Vitro Diagnostic Assays for the Detection of SARS-CoV-2American Journal of Clinical Pathology, 2020
- The prevalence of ophthalmic manifestations in COVID-19 and the diagnostic value of ocular tissue/fluidGraefe's Archive for Clinical and Experimental Ophthalmology, 2020
- Nivel de quimioquina IL-8 en humor acuoso de glaucoma de ángulo abierto: un metaanálisisArchivos de la Sociedad Española de Oftalmología, 2020